DIERGOSPRAY

This brand name is authorized in France

Active ingredients

The drug DIERGOSPRAY contains one active pharmaceutical ingredient (API):

1 Dihydroergotamine
UNII 81AXN7R2QT - DIHYDROERGOTAMINE MESYLATE

Dihydroergotamine binds with high affinity to 5-HT1Dα and 5-HT1Dβ receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors. The therapeutic activity of dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Read about Dihydroergotamine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02CA01 Dihydroergotamine N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CA Ergot alkaloids
Discover more medicines within N02CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 62455371

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈